Simsen Diagnostics is excited to announce its participation in the upcoming Swiss Nordic Bio 2025 conference, which will take place in Zurich on March 13th, 2025. Swiss Nordic Bio is a premier high-level partnering and investor conference designed to connect groundbreaking healthcare innovations with leading investors and industry professionals.
As one of the most exclusive events in the life sciences sector, Swiss Nordic Bio brings together top executives from biotech, pharmaceutical, medtech, and diagnostic companies, along with investors from Switzerland and the Nordic countries. With over 200 participants, 60+ investors, and 400 one-on-one meetings expected, the conference provides a unique platform to foster collaboration and drive innovation in the healthcare industry.
Simsen Diagnostics is proud to be part of this prestigious event, where we will have the opportunity to engage with key stakeholders, pitch to investors, showcase our advancements, and explore potential partnerships that can further accelerate our mission to revolutionize diagnostics.
We look forward to contributing to the vibrant discussions and networking opportunities that make Swiss Nordic Bio a cornerstone event for healthcare innovation.
For more information about the conference, visit the official website: Swiss Nordic Bio 2025.
